# Stereotactic Ablative Radiotherapy in Synchronous and Metachronous Oligo-Metastatic Non Small Cell Lung Cancer

> **NCT06207292** · NA · UNKNOWN · sponsor: **Radiotherapy Oncology Centre "Santa Maria" Hospital** · enrollment: 100 (estimated)

## Conditions studied

- NSCLC
- NSCLC Stage IV
- Oligometastatic Disease
- Non Small Cell Lung Cancer
- Non Small Cell Lung Cancer Metastatic
- EGF-R Positive Non-Small Cell Lung Cancer
- NSCLC Stage IV Without EGFR/ALK Mutation
- Non-Small Cell Adenocarcinoma
- Non-Small Cell Squamous Lung Cancer
- Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
- Synchronous Metastases
- Metachronous Metastasis

## Interventions

- **RADIATION:** Stereotactic Ablative Radiotherapy

## Key facts

- **NCT ID:** NCT06207292
- **Lead sponsor:** Radiotherapy Oncology Centre "Santa Maria" Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-12
- **Primary completion:** 2024-01
- **Final completion:** 2024-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-01-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06207292

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06207292, "Stereotactic Ablative Radiotherapy in Synchronous and Metachronous Oligo-Metastatic Non Small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06207292. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*